These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26473154)

  • 1. Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention.
    Yoo SM; Cho SJ; Cho YY
    J Cancer Prev; 2015 Sep; 20(3):165-71. PubMed ID: 26473154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
    Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
    Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
    Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells.
    Lee CJ; Lee MH; Cho YY
    J Cancer Prev; 2014 Sep; 19(3):199-208. PubMed ID: 25337589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSK2 as a key regulator in human skin cancer.
    Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
    Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
    Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
    Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
    BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isobavachalcone exerts anti‑proliferative and pro‑apoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway.
    Li B; Xu N; Wan Z; Ma L; Li H; Cai W; Chen X; Huang Z; He Z
    Oncol Rep; 2019 Jun; 41(6):3355-3366. PubMed ID: 30942462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer.
    Arul N; Cho YY
    Front Oncol; 2013; 3():201. PubMed ID: 23936765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
    Cho YY
    Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G
    Choi JS; Cho YY
    Biochem Biophys Res Commun; 2023 Jan; 642():66-74. PubMed ID: 36566564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Targeting of ERKs/RSK2 Signaling in Cancers.
    Cho YY
    Curr Pharm Des; 2017 Nov; 23(29):4247-4258. PubMed ID: 28714417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
    Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
    J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
    Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of ERKs, RSK2 and PKR in UVA-induced signal transduction toward phosphorylation of eIF2alpha (Ser(51)).
    Zykova TA; Zhu F; Zhang Y; Bode AM; Dong Z
    Carcinogenesis; 2007 Jul; 28(7):1543-51. PubMed ID: 17404396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.
    Cho YY; Yao K; Pugliese A; Malakhova ML; Bode AM; Dong Z
    Cancer Res; 2009 May; 69(10):4398-406. PubMed ID: 19435896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth.
    Chen W; Lee GE; Jeung D; Byun J; Wu J; Li X; Lee JY; Kang HC; Lee HS; Kim KD; Nam SB; Lee CJ; Kwon YJ; Cho YY
    Cell Death Discov; 2024 Oct; 10(1):442. PubMed ID: 39424777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells.
    Zu X; Xie X; Zhang Y; Liu K; Bode AM; Dong Z; Kim DJ
    Phytother Res; 2019 Sep; 33(9):2337-2346. PubMed ID: 31225674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis.
    Lee CJ; Moon SJ; Jeong JH; Lee S; Lee MH; Yoo SM; Lee HS; Kang HC; Lee JY; Lee WS; Lee HJ; Kim EK; Jhun JY; Cho ML; Min JK; Cho YY
    Cell Death Dis; 2018 Mar; 9(3):401. PubMed ID: 29540697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin-3-methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways.
    Zhao S; Jiang Y; Zhao J; Li H; Yin X; Wang Y; Xie Y; Chen X; Lu J; Dong Z; Liu K
    Mol Carcinog; 2018 Nov; 57(11):1540-1552. PubMed ID: 30035335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.